110 related articles for article (PubMed ID: 32852631)
1. Prognostic impact of abutment to the branches of the superior mesenteric artery in borderline resectable pancreatic cancer.
Imamura T; Yamamoto Y; Sugiura T; Okamura Y; Ito T; Ashida R; Ohgi K; Todaka A; Fukutomi A; Sato R; Aramaki T; Uesaka K
Langenbecks Arch Surg; 2020 Nov; 405(7):939-947. PubMed ID: 32852631
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of middle colic artery as a landmark for superior mesenteric artery - first approach in laparoscopic pancreatoduodenectomy: a prospective study.
Nguyen HH; Nguyen TK; Trinh HS; Do HD; Luong TH; Pham HM; Le VD; Do VM; Chantha P; Pham HQ; Nguyen DV
World J Surg Oncol; 2024 May; 22(1):141. PubMed ID: 38802849
[TBL] [Abstract][Full Text] [Related]
3. Reticular pattern around superior mesenteric artery in computed tomography imaging predicting poor prognosis of pancreatic head cancer.
Kato T; Ban D; Tateishi U; Ogura T; Ogawa K; Ono H; Mitsunori Y; Kudo A; Tanaka S; Tanabe M
J Hepatobiliary Pancreat Sci; 2020 Mar; 27(3):114-123. PubMed ID: 31702106
[TBL] [Abstract][Full Text] [Related]
4. Verification of Resectability Status for Pancreatic Cancer: Radiological and Pathological Analysis of Patients Undergoing Pancreatoduodenectomy With Combined Resection of the Superior Mesenteric Artery.
Makino I; Tajima H; Kitagawa H; Gabata R; Okazaki M; Shinbashi H; Ohbatake Y; Nakanuma S; Saito H; Yamaguchi T; Terai S; Okamoto K; Sakai S; Kinoshita J; Nakamura K; Ninomiya I; Fushida S; Ohta T
Pancreas; 2022 Jan; 51(1):35-40. PubMed ID: 35195593
[TBL] [Abstract][Full Text] [Related]
5. Combination of Distance from Superior Mesenteric Artery and Serum CA19-9 as a Novel Prediction of Local Recurrence in Patients With Pancreatic Cancer Following Resection.
Suzuki F; Fujiwara Y; Hamura R; Haruki K; Sakamoto T; Shiba H; Yanaga K
Anticancer Res; 2019 Mar; 39(3):1469-1478. PubMed ID: 30842184
[TBL] [Abstract][Full Text] [Related]
6. Preoperative assessment of the resectability of pancreatic ductal adenocarcinoma on CT according to the NCCN Guidelines focusing on SMA/SMV branch invasion.
Park SJ; Jang S; Han JK; Kim H; Kwon W; Jang JY; Lee KB; Kim H; Lee DH
Eur Radiol; 2021 Sep; 31(9):6889-6897. PubMed ID: 33740095
[TBL] [Abstract][Full Text] [Related]
7. Posterior 'superior mesenteric artery first' approach for resection of locally advanced pancreatic cancer.
Rose JB; Rocha F; Alseidi A; Helton S
Ann Surg Oncol; 2014 Jun; 21(6):1927-8. PubMed ID: 24370905
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria.
Hong SB; Lee SS; Kim JH; Kim HJ; Byun JH; Hong SM; Song KB; Kim SC
Radiology; 2018 Dec; 289(3):710-718. PubMed ID: 30251929
[TBL] [Abstract][Full Text] [Related]
9. Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy.
Javed AA; Wright MJ; Siddique A; Blair AB; Ding D; Burkhart RA; Makary M; Cameron JL; Narang A; Herman J; Zheng L; Laheru D; Weiss MJ; Wolfgang C; He J
J Gastrointest Surg; 2019 Jan; 23(1):112-121. PubMed ID: 30242644
[TBL] [Abstract][Full Text] [Related]
10. Tips and tricks of the surgical technique for borderline resectable pancreatic cancer: mesenteric approach and modified distal pancreatectomy with en-bloc celiac axis resection.
Hirono S; Yamaue H
J Hepatobiliary Pancreat Sci; 2015 Feb; 22(2):E4-7. PubMed ID: 25366360
[TBL] [Abstract][Full Text] [Related]
11. Reassessment of the clinical significance of portal-superior mesenteric vein invasion in borderline resectable pancreatic cancer.
Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Wakamatsu S; Hoshi S; Hoshi N; Hirabayashi K; Ogata Y
Eur J Surg Oncol; 2017 Jun; 43(6):1068-1075. PubMed ID: 28427822
[TBL] [Abstract][Full Text] [Related]
12. Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma - results of the Conko-007 multicenter trial.
Wittel UA; Lubgan D; Ghadimi M; Belyaev O; Uhl W; Bechstein WO; Grützmann R; Hohenberger WM; Schmid A; Jacobasch L; Croner RS; Reinacher-Schick A; Hopt UT; Pirkl A; Oettle H; Fietkau R; Golcher H
BMC Cancer; 2019 Oct; 19(1):979. PubMed ID: 31640628
[TBL] [Abstract][Full Text] [Related]
13. Inferior Infracolic 'Superior Mesenteric Artery First' Approach with a No-Touch Isolation Surgical Technique in Patients with a Borderline Resectable Cancer of the Pancreatic Head.
Zhu J; Han D; Li X; Pan F; Ma J; Kou J; Fan H; Lang R; He Q
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):976-980. PubMed ID: 27600620
[TBL] [Abstract][Full Text] [Related]
14. Practical significance of pancreatectomy with lymphadenectomy around the superior mesenteric artery for pancreatic cancer: comparison of prognosis after adjusting for major prognostic factors.
Shiozaki H; Shirai Y; Suka M; Hamura R; Horiuchi T; Yasuda J; Furukawa K; Onda S; Gocho T; Ikegami T
Langenbecks Arch Surg; 2021 May; 406(3):703-711. PubMed ID: 33830337
[TBL] [Abstract][Full Text] [Related]
15. Is Pancreatic Head Cancer with Portal Venous Involvement Really Borderline Resectable? Appraisal of an Upfront Surgery Series.
Ohgi K; Yamamoto Y; Sugiura T; Okamura Y; Ito T; Ashida R; Aramaki T; Uesaka K
Ann Surg Oncol; 2017 Sep; 24(9):2752-2761. PubMed ID: 28685356
[TBL] [Abstract][Full Text] [Related]
16. Preoperative radiographic vascular involvement score predicts the prognosis of resected pancreatic head adenocarcinoma.
Onoe S; Kaneoka Y; Maeda A; Takayama Y; Fukami Y
Langenbecks Arch Surg; 2017 May; 402(3):439-446. PubMed ID: 28246964
[TBL] [Abstract][Full Text] [Related]
17. [Analysis on the clinical therapeutic effects of arterial first approach pancreatoduodenectomy in the treatment of borderline resectable pancreatic adenocarcinoma].
Jin G; Zheng KL; Guo SW; Shao Z; Liu C; Shi XH; Liu RD; Bai SJ; Jiang H; Bian Y; Hu XG
Zhonghua Wai Ke Za Zhi; 2017 Dec; 55(12):909-915. PubMed ID: 29224265
[No Abstract] [Full Text] [Related]
18. Periadventitial dissection of the superior mesenteric artery for locally advanced pancreatic cancer: Surgical planning with the "halo sign" and "string sign".
Habib JR; Kinny-Köster B; van Oosten F; Javed AA; Cameron JL; Lafaro KJ; Burkhart RA; Burns WR; He J; Thompson ED; Fishman EK; Wolfgang CL
Surgery; 2021 May; 169(5):1026-1031. PubMed ID: 33036782
[TBL] [Abstract][Full Text] [Related]
19. MAPLE-PD trial (Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer during Pancreaticoduodenectomy): study protocol for a multicenter randomized controlled trial of 354 patients with pancreatic ductal adenocarcinoma.
Hirono S; Kawai M; Okada KI; Fujii T; Sho M; Satoi S; Amano R; Eguchi H; Mataki Y; Nakamura M; Matsumoto I; Baba H; Tani M; Kawabata Y; Nagakawa Y; Yamada S; Murakami Y; Shimokawa T; Yamaue H
Trials; 2018 Nov; 19(1):613. PubMed ID: 30409152
[TBL] [Abstract][Full Text] [Related]
20. In situ surgical procedures for locally advanced pancreatic cancer: partial abdominal evisceration and intestinal autotransplantation.
Amano H; Miura F; Toyota N; Wada K; Katoh K; Hayano K; Kadowaki S; Shibuya M; Maeno S; Eguchi T; Takada T; Asano T
J Hepatobiliary Pancreat Surg; 2009; 16(6):771-6. PubMed ID: 19902139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
